These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38713105)

  • 1. FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms.
    Monaghan RM; Naylor RW; Flatman D; Kasher PR; Williams SG; Keavney BD
    Cardiovasc Res; 2024 Sep; 120(10):1164-1176. PubMed ID: 38713105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases.
    Monaghan RM; Page DJ; Ostergaard P; Keavney BD
    Cardiovasc Res; 2021 Jul; 117(8):1877-1890. PubMed ID: 33067626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole Exome Sequencing Reveals the Major Genetic Contributors to Nonsyndromic Tetralogy of Fallot.
    Page DJ; Miossec MJ; Williams SG; Monaghan RM; Fotiou E; Cordell HJ; Sutcliffe L; Topf A; Bourgey M; Bourque G; Eveleigh R; Dunwoodie SL; Winlaw DS; Bhattacharya S; Breckpot J; Devriendt K; Gewillig M; Brook JD; Setchfield KJ; Bu'Lock FA; O'Sullivan J; Stuart G; Bezzina CR; Mulder BJM; Postma AV; Bentham JR; Baron M; Bhaskar SS; Black GC; Newman WG; Hentges KE; Lathrop GM; Santibanez-Koref M; Keavney BD
    Circ Res; 2019 Feb; 124(4):553-563. PubMed ID: 30582441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploinsufficiency of vascular endothelial growth factor related signaling genes is associated with tetralogy of Fallot.
    Reuter MS; Jobling R; Chaturvedi RR; Manshaei R; Costain G; Heung T; Curtis M; Hosseini SM; Liston E; Lowther C; Oechslin E; Sticht H; Thiruvahindrapuram B; Mil SV; Wald RM; Walker S; Marshall CR; Silversides CK; Scherer SW; Kim RH; Bassett AS
    Genet Med; 2019 Apr; 21(4):1001-1007. PubMed ID: 30232381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.
    Gordon K; Schulte D; Brice G; Simpson MA; Roukens MG; van Impel A; Connell F; Kalidas K; Jeffery S; Mortimer PS; Mansour S; Schulte-Merker S; Ostergaard P
    Circ Res; 2013 Mar; 112(6):956-60. PubMed ID: 23410910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vegfc acts through ERK to induce sprouting and differentiation of trunk lymphatic progenitors.
    Shin M; Male I; Beane TJ; Villefranc JA; Kok FO; Zhu LJ; Lawson ND
    Development; 2016 Oct; 143(20):3785-3795. PubMed ID: 27621059
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Liu N; Gao M
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas.
    Connell FC; Ostergaard P; Carver C; Brice G; Williams N; Mansour S; Mortimer PS; Jeffery S;
    Hum Genet; 2009 Jan; 124(6):625-31. PubMed ID: 19002718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Genetic Risk Variants Inform a Functional Protein Interaction Network for Tetralogy of Fallot.
    Reuter MS; Chaturvedi RR; Jobling RK; Pellecchia G; Hamdan O; Sung WWL; Nalpathamkalam T; Attaluri P; Silversides CK; Wald RM; Marshall CR; Williams SG; Keavney BD; Thiruvahindrapuram B; Scherer SW; Bassett AS
    Circ Genom Precis Med; 2021 Aug; 14(4):e003410. PubMed ID: 34328347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update.
    Gordon K; Spiden SL; Connell FC; Brice G; Cottrell S; Short J; Taylor R; Jeffery S; Mortimer PS; Mansour S; Ostergaard P
    Hum Mutat; 2013 Jan; 34(1):23-31. PubMed ID: 23074044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A NOVEL FLT4 GENE MUTATION AND MR LYMPHANGIOGRAPHY IN A CHINESE FAMILY WITH MILROY DISEASE.
    Liu NF; Yu Z; Luo Y; Sun D; Yan Z
    Lymphology; 2015 Jun; 48(2):93-6. PubMed ID: 26714373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETS transcription factor Etsrp / Etv2 is required for lymphangiogenesis and directly regulates vegfr3 / flt4 expression.
    Davis JA; Koenig AL; Lubert A; Chestnut B; Liu F; Palencia Desai S; Winkler T; Pociute K; Choi K; Sumanas S
    Dev Biol; 2018 Aug; 440(1):40-52. PubMed ID: 29753018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNA helicase Ddx21 controls Vegfc-driven developmental lymphangiogenesis by balancing endothelial cell ribosome biogenesis and p53 function.
    Koltowska K; Okuda KS; Gloger M; Rondon-Galeano M; Mason E; Xuan J; Dudczig S; Chen H; Arnold H; Skoczylas R; Bower NI; Paterson S; Lagendijk AK; Baillie GJ; Leshchiner I; Simons C; Smith KA; Goessling W; Heath JK; Pearson RB; Sanij E; Schulte-Merker S; Hogan BM
    Nat Cell Biol; 2021 Nov; 23(11):1136-1147. PubMed ID: 34750583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HHEX is a transcriptional regulator of the VEGFC/FLT4/PROX1 signaling axis during vascular development.
    Gauvrit S; Villasenor A; Strilic B; Kitchen P; Collins MM; Marín-Juez R; Guenther S; Maischein HM; Fukuda N; Canham MA; Brickman JM; Bogue CW; Jayaraman PS; Stainier DYR
    Nat Commun; 2018 Jul; 9(1):2704. PubMed ID: 30006544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel FLT4 mutation identified in a patient with Milroy disease.
    DiGiovanni RM; Erickson RP; Ohlson EC; Bernas M; Witte MH
    Lymphology; 2014 Mar; 47(1):44-7. PubMed ID: 25109169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical variability in a Japanese hereditary lymphedema type I family with an FLT4 mutation.
    Mizuno S; Yamada Y; Yamada K; Nomura N; Wakamatsu N
    Congenit Anom (Kyoto); 2005 Jun; 45(2):59-61. PubMed ID: 15904433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation.
    Ghalamkarpour A; Holnthoner W; Saharinen P; Boon LM; Mulliken JB; Alitalo K; Vikkula M
    J Med Genet; 2009 Jun; 46(6):399-404. PubMed ID: 19289394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGFR3 is required for button junction formation in lymphatic vessels.
    Jannaway M; Iyer D; Mastrogiacomo DM; Li K; Sung DC; Yang Y; Kahn ML; Scallan JP
    Cell Rep; 2023 Jul; 42(7):112777. PubMed ID: 37454290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical E2fs control lymphangiogenesis through transcriptional regulation of Ccbe1 and Flt4.
    Weijts BG; van Impel A; Schulte-Merker S; de Bruin A
    PLoS One; 2013; 8(9):e73693. PubMed ID: 24069224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-126a Directs Lymphangiogenesis Through Interacting With Chemokine and Flt4 Signaling in Zebrafish.
    Chen J; Zhu RF; Li FF; Liang YL; Wang C; Qin YW; Huang S; Zhao XX; Jing Q
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2381-2393. PubMed ID: 27789478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.